|
This Board consists of experts in the fields of oncology, pharmacology, natural products, drug discovery and development, traditional Chinese medicine, acupuncture, and homeopathy. The Board also contains representatives from the cancer patient community. This Editorial Board meets quarterly to write and update information summaries on complementary and alternative therapies for cancer.
- Jeffrey White, M.D., Editor-in-Chief
National Cancer Institute
Rockville, MD
- Donald I. Abrams, M.D.
UCSF Osher Center for Integrative Medicine
San Francisco, CA
- Lawrence Berk, M.D., Ph.D.
Newark Radiation Oncology
Newark, OH
- John A. Beutler, Ph.D.
National Cancer Institute
Frederick, MD
- Keith Block, M.D.
Block Center for Integrative Cancer Care
Evanston, IL
- Shaw T. Chen, M.D., Ph.D.
Food and Drug Administration
Rockville, MD
- Gordon M. Cragg, Ph.D.
National Cancer Institute
Frederick, MD
- Georgia M. Decker, M.S., R.N., C.S.
Integrative Care
Albany, NY
- Norman R. Farnsworth, Ph.D.
University of Illinois at Chicago, IL
Chicago, IL
|
- Wayne B. Jonas, M.D.
President and CEO, Samueli Institute
Alexandria, VA
- Kara Kelly, M.D.
Columbia University
New York, NY
- Douglas Kinghorn, Ph.D., D.Sc.
Ohio State University
Columbus, OH
- Elena J. Ladas, M.S., R.D.
Columbia University
New York, NY
- Neal Paul Levitan
Community Advocate
Watertown, ME
- Yong Ming Li, M.D., Ph.D.
Warren Hospital
Phillipsburg, NJ
- Patrick J. Mansky, M.D.
The Cancer Team at Bellin Health
Green Bay, WI
- Carl Douglas Rogers
Patient Advocate
Los Angeles, CA
- Xiaoming Tian, M.D., L.Ac.
Academy of Acupuncture & Chinese Medicine
Bethesda, MD
|
|